Immunohistochemical Evaluation of Hormone Receptors in Breast Cancer

Tamoxifen for early breast cancer: an overview of the randomised trials

1998 • 4,082 citations

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1998 • 2,121 citations

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

1999 • 1,991 citations

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial

2001 • 1,075 citations

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

1985 • 995 citations

2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*

2001 • 882 citations

Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer

2001 • 561 citations

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.

1988 • 415 citations

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study

2000 • 309 citations

Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer

1993 • 276 citations

Immunohistochemical detection of steroid receptors in breast cancer: a working protocol

2000 • 190 citations

Biologic Significance of Quantitative Estrogen Receptor Immunohistochemical Assay by Image Analysis in Breast Cancer

1994 • 74 citations

Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials

1996 • 62 citations

Guidelines on endocrine therapy of breast cancerEUSOMA

2002 • 61 citations

Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR

1998 • 31 citations

Immunohistochemical Evaluation of Hormone Receptor for Routine Practice of Breast Cancer: Highly Sensitive Procedures Significantly Contribute to the Correlation with Biochemical Assays

2003 • 13 citations